Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF, PRP, and SVF + PRP for knee osteoarthritis
IRCT20210612051545N8Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jan 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous adipose stromal vascular fraction and platelet-rich plasma in knee osteoarthritis (OA) (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Safety, Pain and 2 more. Started Jan 2026; status: completed.
02
Drugs
autologous adipose stromal vascular fractionplatelet-rich plasma
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20210612051545N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210612051545N8.